Using a Blood Sugar Monitor When You Have Prediabetes

If you have been told you have prediabetes, a continuous glucose monitor (CGM) worn for two to four weeks will teach you more than a fingerstick meter used twice a day, and considerably more than the single annual HbA1c that produced the label in the first place. A CGM samples interstitial glucose every one to five minutes, which means a 14-day sensor produces roughly 4,000 to 20,000 readings instead of 28. That density is what lets you see the shape of your postprandial excursions, the height and timing of your peaks, and your overnight baseline. None of these is visible in an A1c. Whether you should wear one continuously and indefinitely is a different question, and our answer is no. Wear it in campaigns, extract the structure, then re-measure a few times a year.

This page is about measurement and interpretation. It is not medical advice, and decisions about diagnosis, medication, or treatment belong with a clinician who can see your full history.

What the A1c missed and the CGM shows

HbA1c reflects the fraction of hemoglobin that has been non-enzymatically glycated, integrated over the ~90 to 120 day lifespan of a red blood cell. It is a weighted average with no variance information, and it inherits every source of error in red cell turnover: iron deficiency, hemolysis, recent blood donation, pregnancy, and hemoglobin variants all shift it independently of glucose. The oral glucose tolerance test (OGTT) captures a single dynamic response to 75 g of glucose in a fasted state at one moment on one morning, which is informative but has poor day-to-day reproducibility in the same person.

CGM sits between them, and the evidence base for its use in prediabetes specifically has grown quickly. Reviews of the field describe CGM as capable of surfacing postprandial hyperglycemia and glycemic variability that A1c and fasting glucose do not register, and argue that these features appear earlier in the progression toward type 2 diabetes than fasting measures do.¹ A recent review in Endocrine Practice sets out both the case and its limits: CGM in prediabetes is well suited to characterizing exposure and variability and to supporting behavior change, but there are no validated CGM thresholds that define prediabetes or predict progression, and it is not a diagnostic instrument.² In obese and prediabetic youth, CGM-derived measures correlated with both A1c and OGTT results while capturing excursions the clinic tests missed.³

The practical implication is that you should treat CGM as a high-resolution description of how your glucose behaves, and treat A1c, fasting plasma glucose, and OGTT as the instruments that carry the diagnostic definitions.

Which device, and what accuracy to expect

For someone without diabetes, the useful options in the United States are the over-the-counter sensors. These are Dexcom Stelo and Abbott Lingo or Libre Rio, all 15-day wear. All are built on the same sensor chemistry as the prescription versions, with firmware tuned for a non-insulin-using population. The prescription devices (Dexcom G7, FreeStyle Libre 3) are the same hardware with tighter alerting and, in Dexcom’s case, one-minute rather than five-minute or fifteen-minute reporting.

Two differences matter for analysis. The first is sampling interval: Dexcom G7 and Stelo report every five minutes, Libre 3 every minute, Lingo every five. Finer sampling gives you better peak-height estimates, since a coarse grid can miss the apex of a sharp excursion by several minutes. The second is data export. If you plan to do your own analysis, check the export path before you buy. Dexcom’s Clarity web interface exports CSV with timestamp, event type, and glucose value. Abbott’s LibreView exports CSV as well, with separate columns for historic and scan glucose. Both are workable. Neither gives you raw sensor current, so you are analyzing the vendor’s calibrated output. The underlying signal is not available to you.

Expect a mean absolute relative difference (MARD) in the 8 to 10 percent range against venous reference, with worse accuracy in the first 12 to 24 hours after insertion and at low glucose values. For a person in the prediabetic range this means a reading of 140 mg/dL carries roughly ±12 mg/dL of uncertainty, which is fine for comparing your response to oatmeal against your response to eggs and not fine for deciding whether you crossed a diagnostic line. Compression lows, the artifactual drops that occur when you sleep on the sensor, are the most common failure mode. A rapid fall to 50-60 mg/dL lasting 20 to 60 minutes with an equally rapid recovery and no symptoms is almost always compression. Such a fall is almost never hypoglycemia.

A measurement protocol we would use

Wear the sensor for 28 days, which is two 15-day sensors with overlap. Two weeks is the minimum for stable metrics and four weeks reduces the influence of a single unusual week. Discard the first 24 hours of each sensor.

Spend the first 14 days changing nothing. Eat and move as you normally would, and log meals with timestamps. The purpose is a baseline, and a baseline contaminated by good behavior is useless. In the second 14 days, run deliberate tests. Repeat the same standardized meal on three separate mornings to estimate your within-person variability. Then test single variables such as a 20-minute walk beginning 15 minutes after eating, or the same carbohydrate eaten after a protein and fat course rather than first.

Draw a venous fasting glucose, HbA1c, and fasting insulin during the wear period so you can anchor the sensor data against the clinical measures. A fasting insulin alongside fasting glucose lets you compute HOMA-IR, which is a crude but useful index of insulin resistance. The index is interpreted by your clinician. A web calculator does not do that job.

Metrics worth computing from the export

With a CSV of timestamps and glucose values, the analysis is straightforward in pandas. Load with pd.read_csv(path, parse_dates=['Timestamp (YYYY-MM-DDThh:mm:ss)']), then resample to a uniform 5-minute grid with .resample('5min').mean(). Interpolate gaps shorter than 20 minutes only, leaving longer gaps as NaN so they do not silently distort your averages.

The metrics we find most informative, in order:

Mean glucose and standard deviation over the full wear, plus coefficient of variation (CV = SD/mean). CV above roughly 36 percent indicates substantial variability even when mean glucose looks unremarkable. Glycemic variability indices computed from CGM have been shown to carry classification signal for distinguishing normal, prediabetic, and diabetic glucose regulation beyond mean level alone.⁴

Time above 140 mg/dL and time above 180 mg/dL, expressed as percent of wear. There is no validated threshold for prediabetes here, so use these as your own tracking quantity across campaigns rather than as a pass/fail line.²

Nocturnal mean, computed over 02:00 to 06:00 local time. This approximates your fasting baseline without the awakening cortisol rise and is more stable than a single fingerstick.

Per-meal incremental area under the curve over the three hours after each logged meal, with the pre-meal value as the baseline. Use the trapezoid rule and count only area above baseline. Rank your meals by iAUC and you will have a personal ordering that no general glycemic index table can give you.

Peak height and time-to-peak. A peak arriving 45 minutes after eating and resolving by 120 minutes is a different physiology from a peak at 90 minutes still elevated at 180 minutes, even when the maximum values match.

What CGM changes and what it does not

The strongest documented effect of wearing a CGM without diabetes is behavioral. A mixed-methods pilot pairing CGM with low-carbohydrate diet coaching in adults with prediabetes found participants used the real-time feedback to identify and modify specific foods, and reported the immediacy of the signal as the mechanism.⁵ The general argument that real-time glucose feedback functions as a behavior modification tool, rather than as a diagnostic, has been made explicitly for this population.⁶ In people with type 2 diabetes, meta-analysis of CGM versus self-monitoring of blood glucose shows a modest A1c advantage for CGM.⁷

A diagnosis of prediabetes or diabetes rests on fasting plasma glucose, HbA1c, and OGTT, interpreted by a clinician. CGM does not establish that you have prediabetes, tell you when you have crossed into diabetes, or substitute for clinical evaluation. If your sensor shows sustained values you find alarming, or true hypoglycemia with symptoms, that is a reason to see a physician rather than to adjust anything on your own.

Questions people also ask

Should I check my blood sugar daily if I am prediabetic? Daily fingersticks give you little: the information is dominated by when you happened to test. We would rather you wear a CGM for four weeks, analyze it properly, and repeat two or three times a year than sample sparsely every day.

What is a good blood sugar reading for a prediabetic? The clinical definitions use fasting plasma glucose of 100 to 125 mg/dL and HbA1c of 5.7 to 6.4 percent for prediabetes, with diabetes thresholds at 126 mg/dL fasting or 6.5 percent A1c, confirmed on a second test. CGM has no equivalent validated cut points in prediabetes, which is one of the acknowledged gaps in the field.²

What is the most accurate test for prediabetes? The OGTT is the most sensitive single diagnostic test, since it detects post-load elevation that fasting glucose and A1c miss, but it is inconvenient and not highly reproducible within a person. A1c is the most convenient and the most affected by red cell biology. CGM adds resolution neither has but does not carry a diagnostic definition.¹

When should I be concerned about prediabetes? Progression is not inevitable, and the useful response to the label is measurement plus a conversation with a clinician about your full risk picture, including family history, lipids, blood pressure, and body composition. Postprandial excursions and variability that A1c does not capture are part of what makes CGM informative early in this process.¹

Which glucose monitor is best for prediabetes? For self-analysis, we would choose Dexcom Stelo or FreeStyle Libre 3 based on which one’s export you find easier to work with. The sensors are close enough in accuracy that the deciding factor is data access.

Footnotes

1. Xueen Liu, Jiale Zhang. Continuous Glucose Monitoring: A Transformative Approach to the Detection of Prediabetes. Journal of Multidisciplinary Healthcare, 2024. https://doi.org/10.2147/jmdh.s493128 ↩ ↩² ↩³

2. Salwa J. Zahalka, Halis K. Akturk, Rodolfo J. Galindo, et al. Continuous Glucose Monitoring for Prediabetes: Roles, Evidence, and Gaps. Endocrine Practice, 2025. https://doi.org/10.1016/j.eprac.2025.05.742 ↩ ↩² ↩³

3. Christine L. Chan, Laura Pyle, Lindsey Newnes, et al. Continuous Glucose Monitoring and its Relationship to Hemoglobin A1c and Oral Glucose Tolerance Testing in Obese and Prediabetic Youth. The Journal of Clinical Endocrinology & Metabolism, 2015. https://doi.org/10.1210/jc.2014-3612 ↩

4. Giada Acciaroli, Giovanni Sparacino, Liisa Hakaste, et al. Diabetes and Prediabetes Classification Using Glycemic Variability Indices From Continuous Glucose Monitoring Data. Journal of Diabetes Science and Technology, 2017. https://doi.org/10.1177/1932296817710478 ↩

5. Olivia Yost, Melissa DeJonckheere, Spring Stonebraker, et al. Continuous Glucose Monitoring With Low-Carbohydrate Diet Coaching in Adults With Prediabetes: Mixed Methods Pilot Study. JMIR Diabetes, 2020. https://doi.org/10.2196/21551 ↩

6. Nicole Ehrhardt, Enas Al Zaghal. Behavior Modification in Prediabetes and Diabetes: Potential Use of Real-Time Continuous Glucose Monitoring. Journal of Diabetes Science and Technology, 2018. https://doi.org/10.1177/1932296818790994 ↩

7. Rajesh Naidu Janapala, Joseph S Jayaraj, Nida Fathima, et al. Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Type 2 Diabetes Mellitus: A Systematic Review with Meta-analysis. Cureus, 2019. https://doi.org/10.7759/cureus.5634 ↩